# Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir

> **NCT00931281** · PHASE1 · COMPLETED · sponsor: **Abbott** · enrollment: 38 (actual)

## Conditions studied

- HCV Infection

## Interventions

- **DRUG:** ABT-450
- **DRUG:** ritonavir
- **DRUG:** Placebo for ABT-450
- **DRUG:** Placebo for ritonavir

## Key facts

- **NCT ID:** NCT00931281
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-09
- **Final completion:** —
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2010-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00931281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00931281, "Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00931281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*